Welcome to LookChem.com Sign In|Join Free
  • or
7-MORPHOLIN-4-YL-BENZO[1,2,5]OXADIAZOL-4-YLAMINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

842964-18-5

Post Buying Request

842964-18-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

842964-18-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 842964-18-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,2,9,6 and 4 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 842964-18:
(8*8)+(7*4)+(6*2)+(5*9)+(4*6)+(3*4)+(2*1)+(1*8)=195
195 % 10 = 5
So 842964-18-5 is a valid CAS Registry Number.

842964-18-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-Morpholin-4-yl-benzo[1,2,5]oxadiazol-4-ylamine

1.2 Other means of identification

Product number -
Other names 7-(Methylthio)xanthone-3-carboxamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:842964-18-5 SDS

842964-18-5Downstream Products

842964-18-5Relevant academic research and scientific papers

ASPARAGINE ENDOPEPTIDASE (AEP) INHIBITORS, COMPOSITIONS, AND USES RELATED THERETO

-

Page/Page column 4; 63, (2020/12/11)

This disclosure relates to asparagine endopeptidase inhibitors and compositions and uses related thereto. In certain embodiments, the asparagine endopeptidase inhibitors are useful for improving memory, treating or preventing cancer, neurodegenerative diseases, and cognitive disorders. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising an asparagine endopeptidase inhibitor and a pharmaceutically acceptable excipient.

Ubiquitin ligase inhibitors

-

Page/Page column 64, (2008/06/13)

This invention describes compounds and pharmaceutical compositions useful as ubiquitin agent inhibitors, particularly ubiquitin ligase inhibitors. The compounds and pharmaceutical compositions of the invention are useful as inhibitors of the biochemical p

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 842964-18-5